Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 1/20 | 0.55 |
| ▸ | EGFR | P00533 | 1/20 | 0.53 |
| ▸ | AR | P10275 | 3/20 | 0.51 |
| ▸ | P4HB | P07237 | 1/20 | 0.51 |
| ▸ | GUSB | P08236 | 1/20 | 0.49 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.49 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.49 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.48 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.47 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.47 |
| ▸ | ABAT | P80404 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29804271 | 1.00 | MAOB (0.55) | MAOBEGFRARP4HBGUSB | |
| SCHEMBL388024 | 0.84 | AR (0.51) | ARP4HBCYP19A1ALDH1A1CA2 | |
| Methyl Alcohol SCHEMBL27451617 | 0.82 | AR (0.50) | ARP4HBCYP19A1ALDH1A1TSHR | |
| SCHEMBL27758486 | 0.81 | CALM1 (0.60) | ARCYP19A1ALDH1A1TDP1CA2 | |
| SCHEMBL3671816 | 0.81 | NFE2L2 (0.67) | EGFRDYRK1ATRPA1TRIM24ALDH1A1 | |
| SCHEMBL3671817 | 0.81 | NFE2L2 (0.67) | EGFRDYRK1ATRPA1TRIM24ALDH1A1 | |
| SCHEMBL29490258 | 0.81 | AR (0.66) | ARMEN1KMT2AALDH1A1HPGD | |
| SCHEMBL509522 | 0.81 | AR (0.66) | ARMEN1KMT2AALDH1A1HPGD | |
| SCHEMBL4669307 | 0.80 | ALDH1A1 (0.53) | EGFRARP4HBGUSBDYRK1A | |
| SCHEMBL911154 | 0.80 | MAOB (0.55) | MAOBEGFRSLC22A6SLC22A8MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 768 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118638067-A | Novel bio-based epoxy curing agent containing triazole structure and preparation method of epoxy resin | 大连理工大学 | 2024-09-13 | — | — | CN | claimed |
| CN-115368322-B | Preparation method of novel bio-based epoxy resin containing cyano structure | 大连理工大学 | 2024-05-17 | — | — | CN | claimed |
| CN-117567318-A | Method for synthesizing hydroxybenzonitrile from lignin-based aromatic aldehyde | 南京农业大学 | 2024-02-20 | — | — | CN | claimed |
| CN-115368322-A | Preparation method of novel bio-based epoxy resin containing cyano structure | 大连理工大学 | 2022-11-22 | — | — | CN | claimed |
| CN-107118128-B | Preparation method of 3, 4-dihydroxy benzonitrile | 常州佳德医药科技有限公司 | 2020-04-21 | — | — | CN | claimed |
| WO-2013173332-A1 | METHOD FOR SELECTIVE PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM PLANT LIGNIN | Vertichem Corporation (CA) | 2013-11-21 | — | — | WO | claimed |
| US-20130232853-A1 | METHOD FOR SELECTIVE PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM PLANT LIGNIN | THESIS CHEMISTRY, LLC (US) | 2013-09-12 | — | — | US | claimed |
| WO-2010026375-A1 | PHARMACEUTICAL PREPARATION COMPRISING A CATECHIN | LARKINS NICHOLAS JOHN (GB) | 2010-03-11 | — | — | WO | claimed |
| EP-1066269-B1 | TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVES FOR TREATMENT OF HIV INFECTIONS | JANSSEN PHARMACEUTICA NV (BE) | 2005-05-11 | — | — | EP | claimed |
| US-20040261198-A1 | Restructuring and finishing of keratin fibers | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 2004-12-30 | — | — | US | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| EP-0973767-A1 | INDAZOLES OF CYCLIC UREAS USEFUL AS HIV PROTEASE INHIBITORS | Dupont Pharmaceuticals Company (US) | 2000-01-26 | — | — | EP | claimed |
| WO-1999050256-A1 | TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVES FOR TREATMENT OF HIV INFECTIONS | JANSSEN PHARMACEUTICA N.V. (BE) | 1999-10-07 | — | — | WO | claimed |
| WO-1998043969-A1 | INDAZOLES OF CYCLIC UREAS USEFUL AS HIV PROTEASE INHIBITORS | DUPONT PHARMACEUTICALS COMPANY (US) | 1998-10-08 | — | — | WO | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
| EP-0308227-B1 | IMPROVED TEST FOR FECAL OCCULT BLOOD | SMITHKLINE DIAGNOSTICS, INC. (US) | 1992-07-22 | — | — | EP | claimed |
| EP-0308227-A1 | Improved test for fecal occult blood | SMITHKLINE DIAGNOSTICS, INC. (US) | 1989-03-22 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130232853-A1 | METHOD FOR SELECTIVE PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM PLANT LIGNIN | HAAO, HAO2, HACL2 | MAOB 513/4885EGFR 4878/4885AR 4428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.